BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6675157)

  • 1. Discrepant in vitro versus in vivo interaction of M-positive donor red cells with IgG1 anti-M.
    Branch DR; McBroom R; Jones GL
    Rev Fr Transfus Immunohematol; 1983 Dec; 26(6):565-72. PubMed ID: 6675157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four examples of anti-TSEN and three of TSEN-positive erythrocytes.
    Storry JR; Lindsay G; Rolih S; Co A; Rodberg K; Harris T; Reid ME
    Vox Sang; 2000; 79(3):175-9. PubMed ID: 11111237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of MM red cells during hypothermia in two patients with anti-M.
    Kurtz SR; Ouellet R; McMican A; Valeri CR
    Transfusion; 1983; 23(1):37-9. PubMed ID: 6829057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunohematologic study and transfusion approach to patients with public antibodies].
    Solves P; de la Rubia J; Arriaga F; Cervera J; Arnao M; Carpio N; Marty ML
    Sangre (Barc); 1997 Feb; 42(1):25-9. PubMed ID: 9229799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of transfusion needs in a case of immunizing anti-M antibody in a patient with acute myeloid leukemia.
    Navkudkar A; Desai P; Thakkar R; Rajadhyaksha S
    Indian J Pathol Microbiol; 2020; 63(2):251-254. PubMed ID: 32317525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of complement binding by anti-D and anti-M antibodies employing labelled antiglobulin antibodies.
    Freedman J; Massey A; Chaplin H; Monroe MC
    Br J Haematol; 1980 Jun; 45(2):309-18. PubMed ID: 6776980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new low ionic strength test for assessment of pretransfusion compatibility. Studies in vitro and in vivo.
    Szymanski IO; Gandhi JG
    Am J Clin Pathol; 1983 Jul; 80(1):37-42. PubMed ID: 6858963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of Kn(a+) McC(a+) red cells in a patient with anti- "Kna/McCa".
    Ballas SK; Viggiano E; Draper EK
    Transfusion; 1984; 24(1):22-4. PubMed ID: 6695436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological characterization of anti-Mi(a), a red blood cell alloantibody, in Taiwan.
    Lo SC; Chang JS; Lin SW; Lin DT
    Vox Sang; 2002 Aug; 83(2):162-4. PubMed ID: 12201846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of performing red cell elution studies in the pretransfusion testing of patients with positive direct antiglobulin tests.
    Stec N; Shirey RS; Smith B; Kickler TS; Ness PM
    Transfusion; 1986; 26(3):225-6. PubMed ID: 3705136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical significances of red cell alloimmunization and red cell bound immunoglobulin G in polytransfused patients with thalassemias.
    Thedsawad A; Taka O; Wanachiwanawin W
    Hematology; 2019 Dec; 24(1):208-214. PubMed ID: 30479186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A solid phase antibody screen.
    Plapp FV; Sinor LT; Rachel JM; Beck ML; Coenen WM; Bayer WL
    Am J Clin Pathol; 1984 Dec; 82(6):719-21. PubMed ID: 6507384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed hemolytic episodes due to anti-M.
    Furlong MB; Monaghan WP
    Transfusion; 1981; 21(1):45-9. PubMed ID: 7466906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eluate testing following microscopically positive direct antiglobulin tests with anti-IgG.
    Richa E; Benidt G; Tauscher C; Stowers R; Bryant S; Stubbs J
    Ann Clin Lab Sci; 2007; 37(2):167-9. PubMed ID: 17522373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of an antibody causing agglutination of M-positive non-enzymatically glycosylated human red cells.
    Reid ME; Ellisor SS; Barker JM; Lewis T; Avoy DR
    Vox Sang; 1981; 41(2):85-90. PubMed ID: 7331284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Monocyte Monolayer Assay: Past, Present and Future.
    Tong TN; Cen S; Branch DR
    Transfus Med Rev; 2019 Jan; 33(1):24-28. PubMed ID: 30139679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing.
    Heddle NM; O'Hoski P; Singer J; McBride JA; Ali MA; Kelton JG
    Br J Haematol; 1992 Aug; 81(4):579-84. PubMed ID: 1390245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of a positive direct antiglobulin test (autocontrol) in pretransfusion testing revisited.
    Judd WJ; Barnes BA; Steiner EA; Oberman HA; Averill DB; Butch SH
    Transfusion; 1986; 26(3):220-4. PubMed ID: 3705135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
    Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
    Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.
    Natukunda B; Schonewille H; van de Watering L; Brand A
    Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.